-
EASL Expert Interview | Professor Fengmin Lu: From Mechanistic Research to Clinical Cure – Exploring Potential Treatment Strategies for CHB
In the field of chronic HBV infection, the discovery of basic core promoter (BCP) and pre-core (PC) mutations dates back nearly thirty years. However, the potential link between these mutations and the progression of chronic hepatitis B (CHB), as well as their impact on antiviral treatment response, has been a focal point for virologists for…
-
Preview of APACC 2024丨Dr. Owen Tsang: Real-World Experience of Long-Acting ARVs
The Asia-Pacific AIDS & Co-Infections Conference (APACC) 2024 will be held in Hong Kong as a hybrid conference on 27-29 June 2024. During Parallel Session 9: Long-acting ARV, Dr. Owen Tsang from Princess Margaret Hospital will deliver a presentation titled “Real-World Experience – Hong Kong”. In this e-mail interview with “Infectious Disease Frontier” on the…
-
EASL Five-Minute Briefing: Professor Jian Gao Fan Reviews Cutting-Edge Progress in MAFLD Drug Development
On June 8, the European Association for the Study of the Liver (EASL) Annual Meeting concluded successfully in Milan, Italy. This conference brought together top experts and scholars from around the world to discuss the latest technologies and future trends in liver disease treatment. Among the key topics was the development of new drugs for…
-
EHA Expert Interview with Professor Zhihui Li: Safe and Effective Use of Luspatercept Post-Allo-HSCT in Patients with Hematologic Malignancies
The 29th Annual Meeting of the European Hematology Association (EHA) was held from June 13 to 16, 2024, in Madrid, Spain. As the largest international conference in the field of hematology in Europe, it attracts experts and scholars from around the world to share and discuss innovative ideas and the latest scientific and clinical research…
-
EHA China’s Voice | Breakthrough Studies from Professor Huilai Zhang’s Team Unveiled at the EHA Annual Meeting – Deciphering the Genetic Secrets and New Treatment Strategies for Follicular Lymphoma
The 29th European Hematology Association (EHA) Annual Meeting took place from June 13-16, 2024, in Madrid, Spain. At this prestigious event, Professor Huilai Zhang’s team from Tianjin Medical University Cancer Institute and Hospital presented several research studies in poster sessions, highlighting the clinical features, genetic variations, and histological grading of follicular lymphoma. Their work offers…
-
Copy of Professor Jing Pan: Breakthroughs and Prospects of Performance-Enhanced CD33 CAR-T Cells in the Treatment of Relapsed or Refractory AML
In the field of hematologic oncology, treating acute myeloid leukemia (AML) has always been challenging, especially for relapsed or refractory patients. The limitations of traditional chemotherapy underscore the urgent need for innovative treatments. With advancements in immunotherapy, CAR-T cell therapy has introduced new breakthroughs in AML treatment. The 2024 American Society of Clinical Oncology (ASCO)…
-
Welcome the Asia-Pacific AIDS & Co-Infections Conference (APACC) 2024
Over the years, enormous progress has been made in the fight against HIV and co-infections. Both academia and industry have contributed greatly to equipping the medical community with the best medications and expertise possible to optimally treat people living with HIV. However, international platforms for scientific interchange are not always accessible to medical professionals worldwide…
-
EASL Interview with Professor Arun J Sanyal: Breakthroughs in MAFLD Research and Discussion on the “Sugar-Liver Co-Management” Strategy
With the changing modern lifestyle and dietary patterns, Metabolic Associated Fatty Liver Disease (MAFLD) has gradually become one of the significant public health concerns globally. At the 2024 EASL Congress, there have been groundbreaking developments in the pharmacological treatment of MAFLD. Particularly, studies on the dual receptor agonists for Glucagon-Like Peptide-1 (GLP-1) and Glucose-Dependent Insulinotropic…
Connecting Medical Expertise through Media